TY - JOUR
T1 - Hyperglycaemia and vitamin D
T2 - A systematic overview
AU - Neil Thomas, G.
AU - Scragg, R.
AU - Jiang, Chao Q.
AU - Chan, Will
AU - März, Winfried
AU - Pilz, Stefan
AU - Kim, Hyeon C.
AU - Tomlinson, Brian
AU - Bosch, Jos
AU - Lam, Tai H.
AU - Cheung, Bernard M.Y.
AU - Cheng, Kar K.
PY - 2012/1
Y1 - 2012/1
N2 - Vitamin D plays a role in a range of functions that may impact on glycaemic control. In this study we systematically report on clinical studies evaluating the impact of vitamin D on aspects of hyperglycaemia in non-pregnant adults. A total of 1,294 articles, of which 417 were reviews, were identified. No well-designed randomised, controlled trials were identified that specifically investigated the effects of vitamin D supplementation on glucose and insulin concentrations. The majority of the studies that are available were poorly designed, having limited numbers, short study duration, or were conducted in volunteers with normal baseline, as measured by 25-hydroxyvitamin D (25(OH)D), concentrations or used inadequate doses of the supplements to normalise vitamin D concentrations, or used inappropriate analyses. Most studies did not observe improvements in glycaemia, with few exceptions. The results were more equivocal for aspects of insulin resistance. Most found no benefit on measures of insulin resistance, although some did. However, more studies described improved insulin release, although data from the studies to date are really inadequate to provide any reliable conclusions. Well-conducted randomised, controlled trials with adequate vitamin D doses are required to effectively assess whether this vitamin can reduce the incidence of diabetes.
AB - Vitamin D plays a role in a range of functions that may impact on glycaemic control. In this study we systematically report on clinical studies evaluating the impact of vitamin D on aspects of hyperglycaemia in non-pregnant adults. A total of 1,294 articles, of which 417 were reviews, were identified. No well-designed randomised, controlled trials were identified that specifically investigated the effects of vitamin D supplementation on glucose and insulin concentrations. The majority of the studies that are available were poorly designed, having limited numbers, short study duration, or were conducted in volunteers with normal baseline, as measured by 25-hydroxyvitamin D (25(OH)D), concentrations or used inadequate doses of the supplements to normalise vitamin D concentrations, or used inappropriate analyses. Most studies did not observe improvements in glycaemia, with few exceptions. The results were more equivocal for aspects of insulin resistance. Most found no benefit on measures of insulin resistance, although some did. However, more studies described improved insulin release, although data from the studies to date are really inadequate to provide any reliable conclusions. Well-conducted randomised, controlled trials with adequate vitamin D doses are required to effectively assess whether this vitamin can reduce the incidence of diabetes.
KW - Calcium
KW - Hyperglycaemia
KW - Parathyroid hormone
KW - Vascular disease vitamin D
UR - http://www.scopus.com/inward/record.url?scp=84862910469&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84862910469&partnerID=8YFLogxK
U2 - 10.2174/157339912798829223
DO - 10.2174/157339912798829223
M3 - Article
C2 - 22352447
AN - SCOPUS:84862910469
SN - 1573-3998
VL - 8
SP - 18
EP - 31
JO - Current Diabetes Reviews
JF - Current Diabetes Reviews
IS - 1
ER -